BioLife Solutions, Inc. Deferred Costs, Noncurrent
BioLife Solutions, Inc. (BLFS) had Deferred Costs, Noncurrent of $0 as of 2014-12-31, per its 10-K filed 2015-03-12.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2015-03-12
- 2014-12-31: Deferred Costs, Noncurrent $0.00.
- 2014-09-30: Deferred Costs, Noncurrent $0.00.
- 2014-06-30: Deferred Costs, Noncurrent $0.00.
- 2013-12-31: Deferred Costs, Noncurrent $114.87K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-12 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-06 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-07 |
| 2013-12-31 | $114.87K 10-K · filed 2015-03-12 |
| 2013-09-30 | $129.14K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $143.40K 10-Q · filed 2013-08-12 |
| 2013-03-31 | $157.51K 10-Q · filed 2013-05-14 |
| 2012-12-31 | $171.46K 10-K · filed 2014-02-12 |
| 2012-09-30 | $189.85K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $208.25K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $85.00K 10-Q · filed 2012-05-14 |
| 2011-12-31 | $112.04K 10-K · filed 2013-03-29 |
| 2011-09-30 | $139.38K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $70.47K 10-Q · filed 2011-08-12 |
| 2010-12-31 | $97.22K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |